Syngene's Q1 Performance Chart 2023
Drug Updates

Syngene International Invests in Future Growth While Enjoying Robust Q1 Performance

Syngene International Limited is making significant waves in the healthcare sector. The company reported impressive first-quarter results with revenues up 26% to Rs. 832 crores and a PAT surge of 26% to Rs.93 crores. This strong financial footing allows Syngene to embark on strategic investments to pave the way for future growth. These include the […]